Gyre Therapeutics (GYRE) Stock Chart & Stock Price History $11.12 +1.13 (+11.31%) (As of 12/17/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Gyre Therapeutics Stock Price Performance 5 Day Performance+15.35%1 Month Performance-11.89%3 Month Performance-19.83%6 Month Performance+2.96%Year-To-Date Performance-56.71%1 Year Performance-55.27% Receive GYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. GYRE Stock Chart for Wednesday, December, 18, 2024 GYRE Chart by TradingView Gyre Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$9.99$11.12+11.31%$11.44$10.0079,406 shs$1.04 billion12/16/2024$9.64$9.99+3.63%$10.31$9.67127,737 shs$934.28 million12/13/2024$9.78$9.64-1.43%$10.22$9.61138,661 shs$901.53 million12/12/2024$10.02$9.78-2.40%$10.46$9.75186,896 shs$914.64 million12/11/2024$10.99$10.02-8.83%$11.04$10.02139,147 shs$937.07 million12/10/2024$10.74$10.99+2.33%$11.34$10.75185,460 shs$1.03 billion Get the Latest News and Ratings for GYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$11.51$10.74-6.69%$12.58$10.35256,033 shs$1.00 billion12/06/2024$10.47$11.51+9.93%$11.77$10.75186,001 shs$1.08 billion12/05/2024$9.92$10.47+5.54%$10.98$10.00174,924 shs$979.15 million12/04/2024$11.01$9.92-9.90%$11.33$9.54196,331 shs$927.72 million12/03/2024$11.83$11.01-6.93%$12.28$11.01139,042 shs$1.03 billion12/02/2024$12.51$11.83-5.44%$12.98$11.78132,331 shs$1.11 billion11/29/2024$11.70$12.51+6.92%$13.20$12.00114,930 shs$1.17 billion11/28/2024$11.70$11.70$12.55$11.5079,807 shs$1.09 billion11/27/2024$12.09$11.70-3.23%$12.55$11.5079,807 shs$1.09 billion11/26/2024$11.63$12.09+3.96%$12.42$11.65112,245 shs$1.13 billion11/25/2024$11.29$11.63+3.01%$12.37$11.5061,629 shs$1.09 billion11/22/2024$11.75$11.29-3.91%$12.19$11.0697,344 shs$1.06 billion11/21/2024$12.91$11.75-8.99%$12.91$11.7091,297 shs$1.10 billion11/20/2024$12.92$12.91-0.08%$13.24$12.8234,854 shs$1.21 billion11/19/2024$12.62$12.92+2.38%$13.14$12.3328,913 shs$1.21 billion11/18/2024$13.12$12.62-3.81%$13.54$12.54127,050 shs$1.18 billion Related Companies Organon & Co. Stock Chart PTC Therapeutics Stock Chart Rhythm Pharmaceuticals Stock Chart MoonLake Immunotherapeutics Stock Chart ImmunityBio Stock Chart Janux Therapeutics Stock Chart Verona Pharma Stock Chart Xenon Pharmaceuticals Stock Chart Zai Lab Stock Chart ACADIA Pharmaceuticals Stock Chart Receive GYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GYRE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
